Guardant Health
GH
#1450
Rank
HK$119.38 B
Marketcap
HK$900.32
Share price
17.09%
Change (1 day)
187.73%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -HK$3.4 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$1.08 Billion. In 2025 the company made an earning of -HK$3.27 Billion, an increase over its 2024 earnings that were of -HK$3.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$3.4 Billion3.78%
2025 -HK$3.27 Billion-4.03%
2024 -HK$3.41 Billion-9.12%
2023 -HK$3.75 Billion-26.73%
2022 -HK$5.12 Billion69.96%
2021 -HK$3.02 Billion56.35%
2020 -HK$1.93 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-HK$4.92 Billion 44.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$2.25 Billion-34.13%๐Ÿ‡บ๐Ÿ‡ธ USA